Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Lesaka Technologies increased the annual base salary for Group CFO Dan Smith to approximately $447,053 and established fiscal 2027 cash incentive award structures for four senior executives. The incentive awards for Messrs. Heilbron, Kola, Mali, and Smith are based on a mix of quantitative financial performance and qualitative objectives, with maximum potential payouts of 120% of their respective base salaries.
BioMarin Pharmaceutical Inc. increased its board size from ten to eleven members and appointed Robert Plenge, M.D., Ph.D., as an independent director. Dr. Plenge will receive standard non-employee director fees and was granted restricted stock units (RSUs) valued at $400,000, which vest just prior to the company's next annual meeting.
Oportun Financial Corporation has appointed William Franklin as Chief Financial Officer, effective September 8, 2026. Mr. Franklin's compensation package includes a $500,000 base salary, a $200,000 signing bonus, and a new hire equity award of 276,626 restricted stock units (RSUs) vesting over three years.
Coty Inc. entered into a Transition Agreement with outgoing CFO Laurent Mercier, who will serve as Strategic CEO Advisor through June 30, 2027. Mercier will maintain his €825,000 annual base salary and receive a one-time fixed bonus of €290,000, while assisting with the transition to new CFO Soraya Benchikh.
SharonAI Holdings entered into a Deed of Release with co-founder Andrew Leece, transitioning him from Chief Operating Officer to Head of Strategic Partnerships. The agreement sets a fixed employment term through March 2027 with an annual base salary of approximately $400,000 USD and a fixed short-term incentive of AUD$422,535. Leece will also retain 151,219 unvested RSUs while forfeiting other previously granted equity awards.